Frontier Biotechnologies Hits Day High with 12.13% Surge in Stock Price

Frontier Biotechnologies, Inc. (China) has experienced a significant surge in its stock price, gaining 12.13% on June 29, 2026. The stock reached an intraday high of CNY 22.00, marking a notable performance against the backdrop of the China Shanghai Composite, which only increased by 1.16% on the same day. In terms of performance metrics, Frontier Biotechnologies has shown impressive growth over various time frames. Over the past week, the stock has risen by 20.75%, while its one-month performance stands at 10.0%. Year-to-date, the stock has increased by 21.88%, and over the past year, it has delivered a remarkable return of 123.8%. In comparison, the China Shanghai Composite has lagged, with a one-year performance of just 18.97%. Despite these positive trends, the company faces challenges, including a low return on capital employed (ROCE) of 0% and a negative net worth. The market capitalization of Frontier Biotechnologies is currently CNY 3,736 million, placing it in the mid-cap category within the pharmaceuticals and biotechnology industry.